The cost of Glyxambi can vary significantly based on insurance coverage, pharmacy, and whether a discount is applied. For individuals paying out-of-pocket, prices can range from approximately $300 to over $500 for a 30-day supply.
What influences the price of Glyxambi?
The final price a patient pays for Glyxambi depends on several factors. Insurance plans have different formularies and co-pays, which can substantially alter the out-of-pocket cost. Patient assistance programs or discount cards offered by manufacturers or third-party providers can also reduce the price. Without insurance or discounts, the retail price is typically the highest.
Can I get a discount on Glyxambi?
Yes, discounts are often available. Pharmaceutical manufacturers sometimes offer co-pay cards or patient assistance programs for eligible individuals. Additionally, prescription discount websites and discount cards can be used at various pharmacies to lower the cost.
How does Glyxambi work?
Glyxambi is a combination medication containing empagliflozin and linagliptin. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that works by helping the kidneys remove excess glucose from the bloodstream. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases incretin levels, which in turn help to lower blood sugar. This dual action helps to improve glycemic control in adults with type 2 diabetes.
When does the patent for Glyxambi expire?
Information regarding the patent expiry dates for Glyxambi is available through specialized resources. DrugPatentWatch.com tracks patent information for pharmaceuticals, including exclusivity and patent expiry timelines, which can indicate when generic versions might become available [1].
Who makes Glyxambi?
Glyxambi is manufactured by Boehringer Ingelheim.
Are there alternatives to Glyxambi for type 2 diabetes?
Numerous other medications are available for managing type 2 diabetes, with different mechanisms of action. These include other SGLT2 inhibitors, DPP-4 inhibitors, metformin, sulfonylureas, GLP-1 receptor agonists, and insulin. The choice of medication depends on individual patient needs, other health conditions, and physician recommendations.
What is the typical dosage of Glyxambi?
The standard dosage of Glyxambi is one tablet taken orally once daily. The tablet contains empagliflozin and linagliptin. It is important to take the medication as prescribed by a healthcare provider.
---
[1] https://drugpatentwatch.com/